Detalhe da pesquisa
1.
Loss-of-function mutations in ndh do not confer delamanid, ethionamide, isoniazid, or pretomanid resistance in Mycobacterium tuberculosis.
Antimicrob Agents Chemother
; 68(1): e0109623, 2024 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38038476
2.
Spatial relationships of intra-lesion heterogeneity in Mycobacterium tuberculosis microenvironment, replication status, and drug efficacy.
PLoS Pathog
; 18(3): e1010459, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35344572
3.
A descriptive study on isoniazid resistance-associated mutations, clustering and treatment outcomes of drug-resistant tuberculosis in a high burden country.
Eur J Clin Microbiol Infect Dis
; 43(1): 73-85, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37943394
4.
Discovery of 1,2,3-triazole incorporated indole-piperazines as potent antitubercular agents: Design, synthesis, in vitro biological evaluation, molecular docking and ADME studies.
Bioorg Med Chem
; 98: 117562, 2024 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38184947
5.
Unlocking InhA: Novel approaches to inhibit Mycobacterium tuberculosis.
Bioorg Chem
; 146: 107250, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38460337
6.
Application of the Hollow-Fiber Infection Model to Personalized Precision Dosing of Isoniazid in a Clinical Setting.
J Korean Med Sci
; 39(13): e104, 2024 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38599596
7.
Pangenomic analyses of tuberculosis strains to identify resistomes using computational approaches.
J Pak Med Assoc
; 74(1 (Supple-2)): S74-S78, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38385476
8.
Antibiotic Adjuvant 4-Hexylresorcinol Enhances the Efficiency of Antituberculosis Drugs.
Bull Exp Biol Med
; 176(4): 466-471, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38488964
9.
Evaluating the Impact of the Tyr158 pKa on the Mechanism and Inhibition of InhA, the Enoyl-ACP Reductase from Mycobacterium tuberculosis.
Biochemistry
; 62(12): 1943-1952, 2023 06 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37270808
10.
Non-actionable Results, Accuracy, and Effect of First- and Second-line Line Probe Assays for Diagnosing Drug-Resistant Tuberculosis, Including on Smear-Negative Specimens, in a High-Volume Laboratory.
Clin Infect Dis
; 76(3): e920-e929, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35788278
11.
Inoculum-dependent bactericidal activity of a Mycobacterium tuberculosis MmpL3 inhibitor.
Microbiology (Reading)
; 169(6)2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37334886
12.
Quantification of Isoniazid-Heteroresistant Mycobacterium tuberculosis Using Droplet Digital PCR.
J Clin Microbiol
; 61(6): e0188422, 2023 06 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37195177
13.
Clinical Evaluation of the XDR-LFC Assay for the Molecular Detection of Isoniazid, Rifampin, Fluoroquinolone, Kanamycin, Capreomycin, and Amikacin Drug Resistance in a Prospective Cohort.
J Clin Microbiol
; 61(3): e0147822, 2023 03 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36757183
14.
Luteolin as a potential host-directed immunotherapy adjunct to isoniazid treatment of tuberculosis.
PLoS Pathog
; 17(8): e1009805, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34415976
15.
Study of drug interaction, mutant frequency and mutant prevention concentration of DFMBT against Mycobacterium tuberculosis H37RV.
Microb Pathog
; 176: 106023, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36736799
16.
Anticancer effect of aromatic isoniazid derivatives in human gastric adenocarcinoma cells.
Toxicol Appl Pharmacol
; 481: 116767, 2023 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38007073
17.
The physiological effect of rimI/rimJ silencing by CRISPR interference in Mycobacterium smegmatis mc2155.
Arch Microbiol
; 205(5): 211, 2023 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37119317
18.
Multi-drug resistant and rifampin-resistant tuberculosis in transplant recipients.
Transpl Infect Dis
; 25(4): e14088, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37335213
19.
Molecular identification of multiple drug resistance (MDR) strain of Mycobacterium tuberculosis.
Mol Biol Rep
; 50(12): 10271-10275, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37971566
20.
A host blood transcriptional signature differentiates multi-drug/rifampin-resistant tuberculosis (MDR/RR-TB) from drug susceptible tuberculosis: a pilot study.
Mol Biol Rep
; 50(4): 3935-3943, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36749527